🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in India / NCT03773965
Recruiting Phase 3

A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis

NCT03773965 · tracked via the Priya Life Science India tracker
Sponsor
Eli Lilly and Company
Phase
Phase 3
Started
2019-04-05
Last updated
2026-08-24

Condition(s) studied

Juvenile Idiopathic Arthritis

Investigational drug(s) / intervention(s)

Baricitinib

Baricitinib: Administered orally.

Study summary

The reason for this study is to see if the study drug baricitinib is safe and effective in the treatment of JIA in participants ages 1 to 17. This study is for participants that have been enrolled in studies I4V-MC-JAHV (NCT03773978) or I4V-MC-JAHU.

Eligibility

Sex
ALL
Min age
1 Year
Max age
18 Years
Healthy volunteers
No
Inclusion Criteria: * Participants must have completed a previous study of baricitinib for the treatment of JIA. Exclusion Criteria: * Participants must not have had a permanent discontinuation of baricitinib in the prior study. * Participants must have not developed an allergy to baricitinib.

Primary outcome measure(s)

Trial sites (78)

FacilityCityRegionStatus
Instituto CAICI SRL Rosario Argentina Recruiting
Centro de Investigaciones Médicas Tucuman SAN M. de Tucuman Argentina Recruiting
Royal Children's Hospital Melbourne Australia Not Yet Recruiting
Perth Children's Hospital Perth Australia Not Yet Recruiting
The Children's Hospital at Westmead Westmead Australia Active Not Recruiting
Landeskrankenhaus Bregenz Bregenz Austria Completed
Cliniques universitaires Saint-Luc Brussels Belgium Completed
UZ Gent Ghent Belgium Recruiting
UZ Leuven Leuven Belgium Recruiting
Faculdade de Medicina da UNESP Botucatu Brazil Recruiting
Universidade Federal de Sao Paulo São Paulo Brazil Recruiting
Instituto da Crianca do Hospital das Clinicas da FMUSP São Paulo Brazil Recruiting
Beijing Children's hospital, Capital Medical University Beijing China Active Not Recruiting
The Children's Hospital of Chongqing Medical University Chongqing China Active Not Recruiting
Childrens Hospital of Nanjing Medical University Nanjing China Not Yet Recruiting
Children's Hospital of Soochow University Suzhou China Recruiting
Detska nemocnice FN Brno Brno Czechia Recruiting
Vseobecna fakultni nemocnice v Praze Prague Czechia Recruiting
Fakultni nemocnice Motol Prague Czechia Recruiting
Aarhus Universitetshospital, Skejby Aarhus Denmark Recruiting
Hospices Civils de Lyon - Hôpital Femme Mère Enfant Bron France Recruiting
Hôpitaux Universitaires Paris Sud - Hôpital Bicêtre Le Kremlin-Bicêtre France Recruiting
Centre Hospitalier Universitaire de Nîmes - Hôpital Universitaire Carémeau Nîmes France Recruiting
Hôpital Universitaire Necker Enfants Malades Paris France Recruiting
Centre Hospitalier Universitaire de Poitiers Poitiers France Recruiting
Helios Klinikum Berlin-Buch Berlin Germany Active Not Recruiting
Charité Campus Virchow-Klinikum Berlin Germany Completed
Praxis Kinder- und Jugendrheumatologie Dr. Ivan Foeldvari Hamburg Germany Active Not Recruiting
Universitätsklinikum Heidelberg Heidelberg Germany Completed
Asklepios Klinik Sankt Augustin Sankt Augustin Germany Active Not Recruiting
Universitaetsklinikum Tuebingen Tübingen Germany Active Not Recruiting
Sri Ramachandra MedicaL College & Research Institute Chennai India Completed
Sir Ganga Ram Hospital New Delhi India Recruiting
Christian Medical College Vellore Vellore India Recruiting
Rambam Health Care Campus Haifa Israel Recruiting
Meir Medical Center Kfar Saba Israel Recruiting
Schneider Children's Medical Center Petah Tikva Israel Recruiting
Sheba Medical Center Ramat Gan Israel Recruiting
Azienda Ospedaliera Spedali Civili di Brescia Brescia Italy Active Not Recruiting
Azienda Sanitaria Locale n. 2 - Lanciano Vasto Chieti Chieti Italy Completed

+ 38 more sites — see the full list on the official registry below.

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03773965 on ClinicalTrials.gov ↗ ← All trials in India